H1B Report
Side-by-side comparison

Teva Pharmaceuticals USA, Inc. vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Teva Pharmaceuticals USA, Inc.
NJRank #FEIN 22-1734359
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricTeva Pharmaceuticals USA, Inc.Deloitte Consulting LLP
Total filings34079,212
Certified %80.00%98.22%
Denied %0.88%1.09%
Withdrawn %6.18%0.61%
Cert-withdrawn %12.94%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJPA

Outcomes — Teva Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 80.0%, Cert-withdrawn 12.9%, Withdrawn 6.2%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified80.0%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%
Certified80.0%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Teva Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20265
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,357
FY20113,610
FY20124,667
FY20136,024
FY20146,873
FY20157,505
FY20167,371
FY20177,040
FY201816,029
FY20197,724
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20261,792

Top 5 occupations — Teva Pharmaceuticals USA, Inc.

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Teva Pharmaceuticals USA, Inc. vs Deloitte Consulting LLP — H-1B Sponsor Comparison · H1B Report